Turnstone Biologics Corp. (TSBX)
Aug 11, 2025 - TSBX was delisted (reason: acquired by XOMA)
0.3550
0.00 (0.00%)
Inactive · Last trade price
on Aug 8, 2025
Turnstone Biologics Stock Forecast
TSBX's stock price has decreased by -83.6% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Turnstone Biologics stock had an average target of 4.75, with a low estimate of 0.50 and a high estimate of 10.
Price Target: $4.75 (+1,238.03%)
Analyst Consensus: Buy
* Price targets were last updated on Oct 14, 2024.
Analyst Ratings
The average analyst rating for Turnstone Biologics stock from 3 stock analysts was "Buy". This means that analysts believed this stock was likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy → Hold Downgrades $10 → $0.5 | Strong Buy → Hold | Downgrades | $10 → $0.5 | +40.85% | Oct 14, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $12 → $10 | Strong Buy | Maintains | $12 → $10 | +2,716.90% | Aug 19, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $20 → $3.75 | Buy | Maintains | $20 → $3.75 | +956.34% | Aug 19, 2024 |
| B of A Securities | B of A Securities | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +4,970.42% | Aug 15, 2023 |
| Piper Sandler | Piper Sandler | Buy Initiates $20 | Buy | Initiates | $20 | +5,533.80% | Aug 15, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.70
from -3.07
EPS Next Year
-0.52
from -0.70
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -0.72 | -0.54 |
| Avg | -0.70 | -0.52 |
| Low | -0.68 | -0.50 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.